DNA Vaccine

被引：83

作者：

Cui, Zhengrong ^{[1
]}

机构：

[1] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA

来源：

NON-VIRAL VECTORS FOR GENE THERAPY, SECOND EDITION: PART 2 | 2005年 / 54卷

关键词：

D O I：

10.1016/S0065-2660(05)54011-2

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The DNA vaccine has proven to be one of the most promising applications in the field of gene therapy. Due to its unique ability to readily induce humoral as well as cellular immune responses, it attracted great interest when the concept was first confirmed in the early 1990s. After thousands of articles related to the DNA vaccine were published, scientists began to realize that although the DNA vaccine is very effective in small animal models, its effectiveness in recent clinical trails is rather disappointing. Therefore, current effort has been shifted to understanding the different performance of the DNA vaccine in mouse and large animal models and on how to transfer the success of the DNA vaccine in small animals to large animals and humans. (C) 2005, Elsevier Inc.

引用

页码：257 / 289

页数：33

共 102 条

[1]

Agadjanyan MG, 1999, J IMMUNOL, V162, P3417

[2] Toll-like receptors: critical proteins linking innate and acquired immunity [J].

Akira, S ;

Takeda, K ;

Kaisho, T .

NATURE IMMUNOLOGY, 2001, 2 (08) :675-680

[3] Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].

Alexopoulou, L ;

Holt, AC ;

Medzhitov, R ;

Flavell, RA .

NATURE, 2001, 413 (6857) :732-738

[4] Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].

Aliprantis, AO ;

Yang, RB ;

Mark, MR ;

Suggett, S ;

Devaux, B ;

Radolf, JD ;

Klimpel, GR ;

Godowski, P ;

Zychlinsky, A .

SCIENCE, 1999, 285 (5428) :736-739

[5] Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques [J].

Baba, TW ;

Liska, V ;

Khimani, AH ;

Ray, NB ;

Dailey, PJ ;

Penninck, D ;

Bronson, R ;

Greene, MF ;

McClure, HM ;

Martin, LN ;

Ruprecht, RM .

NATURE MEDICINE, 1999, 5 (02) :194-203

[6] Dendritic cells and the control of immunity [J].

Banchereau, J ;

Steinman, RM .

NATURE, 1998, 392 (6673) :245-252

[7] THE CD40 ANTIGEN AND ITS LIGAND [J].

BANCHEREAU, J ;

BAZAN, F ;

BLANCHARD, D ;

BRIERE, F ;

GALIZZI, JP ;

VANKOOTEN, C ;

LIU, YJ ;

ROUSSET, F ;

SAELAND, S .

ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922

[8] Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain [J].

Baud, V ;

Liu, ZG ;

Bennett, B ;

Suzuki, N ;

Xia, Y ;

Karin, M .

GENES & DEVELOPMENT, 1999, 13 (10) :1297-1308

[9] Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice [J].

Bender, BS ;

Ulmer, JB ;

DeWitt, CM ;

Cottey, R ;

Taylor, SF ;

Ward, AM ;

Friedman, A ;

Liu, MA ;

Donnelly, JJ .

VACCINE, 1998, 16 (18) :1748-1755

[10] Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].

Bennett, SRM ;

Carbone, FR ;

Karamalis, F ;

Flavell, RA ;

Miller, JFAP ;

Heath, WR .

NATURE, 1998, 393 (6684) :478-480

← 1 2 3 4 5 6 7 8 9 10 →